Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2007-04-27
2010-06-01
Schwadron, Ron (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S001490, C424S009100, C424S144100, C424S155100, C424S174100, C424S173100, C530S387700, C530S388700, C530S388730, C530S388800
Reexamination Certificate
active
07727525
ABSTRACT:
The present invention provides anti-CD20 antibody fragments for use as in vivo imaging probes and as therapeutic moieties for the diagnosis and treatment of NHL.
REFERENCES:
patent: 4348376 (1982-09-01), Goldenberg
patent: 4454106 (1984-06-01), Gansow et al.
patent: 4460559 (1984-07-01), Goldenberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4676980 (1987-06-01), Segal et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4831175 (1989-05-01), Gansow et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5091513 (1992-02-01), Huston et al.
patent: 5260203 (1993-11-01), Ladner et al.
patent: 5455030 (1995-10-01), Ladner et al.
patent: 5518889 (1996-05-01), Ladner et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5595721 (1997-01-01), Kaminski et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5736137 (1998-04-01), Anderson et al.
patent: 5843398 (1998-12-01), Kaminski et al.
patent: 5856456 (1999-01-01), Whitlow
patent: 6015542 (2000-01-01), Kaminski et al.
patent: 6090365 (2000-07-01), Kaminski et al.
patent: 6287537 (2001-09-01), Kaminski et al.
patent: 6399061 (2002-06-01), Anderson et al.
patent: 6455043 (2002-09-01), Grillo-Lopez
patent: 6565827 (2003-05-01), Kaminski et al.
patent: 6682734 (2004-01-01), Anderson et al.
patent: 2003/0219433 (2003-11-01), Hansen et al.
patent: 91/00360 (1991-01-01), None
patent: 92/00373 (1992-01-01), None
patent: 93/08829 (1993-05-01), None
Perez et al., ChemBioChem, 5:261-264, 2004.
Altschul, S.F. et al., “Basic Local Alignment Search Tool,” J. Mol. Biol. 215:403-410 (1990).
Altschul, S.F. et al., “Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs,” Nucleic Acids Res. 25:3389-3402 (1997).
Angal, S. et al., “A Single Amino Acid Substitution Abolishes the Heterogeneity of Chimeric Mouse/Human (IgG4) Antibody,” Mol. Immun. 30:105-108 (1993).
Bansinath, M. et al., “Chronic Administration of a Nitric Oxide Synthase Inhibitor, Nω-Nitro-L-Arginine, and Drug-Induced Increase in Cerebellar Cyclic GMP In Vivo,” NeuroChem. Res. 18:1063-1066 (1993).
Bebbington, C.R. et al., “High-Level Expression of a Recombinant Antibody From Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker,” Biotech. 10:169-175 (1992).
Bergman, Y. et al., “Characterization of a Carcinogen-Induced Murine B Lymphocyte Cell Line of C3H/eB Origin,” Eur. J. Immunol. 7:413-417 (1977).
Bloom, J.W. et al., “Intrachain Disulfide Bond in the Core Hinge Region of Human IgG4,” Protein Sci. 6:407-415 (1997).
Cockett, M.I. et al., “The Use of Engineered E1A Genes to Transactivate the hCMV-MIE Promoter in Permanent CHO Cell Lines,” Nucleic Acid Res. 19:319-325 (1990).
Cole, S.P.C. et al., “The EBV-Hybridoma Technique and Its Application to Human Lung Cancer,” Monoclonal Antibodies and Cancer Therapy, pp. 77-96 (1985).
Defrise, M. et al., “Exact and Approximate Rebinning Algorithms for 3-D PET Data,” IEEE Trans. Med. Imaging 16:145-158 (1997).
Dikmen, Z.G. et al., “A New Diagnostic System in Cancer Research: Bioluminescent Imaging (BLI),” Turk J. Med. Sci. 35:65-70 (2005).
Fishwild, D.M. et al., “High-Avidity Human IgGκ Monoclonal Antibodies From a Novel Strain of Minilocus Transgenic Mice,” Nat. Biotech. 14:845-851 (1996).
Flusberg, B.A. et al., “Fiber-Optic Fluorescence Imaging,” Nature Methods 2:941-950 (2005).
Flusberg, B.A. et al., “In Vivo Brain Imaging Using a Portable 3.9 Gram Two-Photon Fluorescence Microendoscope,” Optics Letters 30:2272-2274 (2005).
Fraker, P.J. et al., “Protein and Cell Membrane Iodinations with a Sparingly Soluble Chloroamide, 1,3,4,6-Tetrachloro-3a,6a-Diphenylglycoluril,” Biochem. & Biophys. Res. Commun. 80:849-857 (1978).
Funovics, M.A. et al., “Catheter-based In Vivo Imaging of Enzyme Activity and Gene Expression: Feasibility Study in Mice,” Radiology 231:659-666 (2004).
Galfre, G. et al., “Preparation of Monoclonal Antibodies: Strategies and Procedures,” Methods in Enzymology 73:3-46 (1981).
Greenwood, F.C. et al., “The Preparation of131I-Labelled Human Growth Hormone of High Specific Radioactivity,” Biochem. J. 89:114-123 (1963).
Gurfinkel, M. et al., “Near-Infrared Fluorescence Optical Imaging and Tomography,” Disease Markers 19:107-121 (2004).
Henikoff, S. et al., “Amino Acid Substitution Matrices from Protein Blocks,” Proc. Natl. Acad. Sci. USA 89:10915-10919 (1992).
Iwasaki, T. et al., “NG-Nitro-L-Arginine Methyl Ester Inhibits Bone Metastasis After Modified Intracardiac Injection of Human Breast Cancer Cells in a Nude Mouse Model,” Jpn. J. Cancer Res. 88:861-866 (1997).
Karlin, S. et al., “Applications and Statistics for Multiple High-Scoring Segments in Molecular Sequences,” Proc. Natl. Acad. Sci. USA 90:5873-5877 (1993).
Kenanova, V. et al., “Tailoring the Pharmacokinetics and Positron Emission Tomography Imaging Properties of Anti-Carcinoembryonic Antigen Single-Chain Fv-Fc Antibody Fragments,” Cancer Res. 65:622-631 (2005).
Kinahan, P.E. et al., “Analytic 3D Image Reconstruction Using All Detected Events,” IEEE Transactions on Nulear Sci. 36:964-968 (1989).
Kohler, G. et al., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,” Nature 256:495-497 (1975).
Kozbor, D. et al., “The Production of Monoclonal Antibodies from Human Lymphocytes,” Immun. Today 4:72-79 (1983).
Lewis, M.R. et al., “An Improved Method for Conjugating Monoclonal Antibodies withN-Hydroxysulfosuccinimidyl DOTA,” Bioconjugate Chem. 12:320-324 (2001).
Loening, A.M. et al., “AMIDE: A Free Software Tool for Multimodality Medical Image Analysis,” Mol. Imaging 2:131-137 (2003).
Lonberg, N. et al., “Antigen-Specific Human Antibodies from Mice Comprising Four Distinct Genetic Modifications,” Nature 368:856-859 (1994).
Lonberg, N. et al., “Human Antibodies from Transgenic Mice,” Intern. Rev. Immunol. 13:65-93 (1995).
Magerstadt, M., “In Vitro Characterization of Therapeutic Radioimmunoconjugates,” Antibody Conjugates and Malignant Disease 93-109 (1991).
Mahmood, U. et al., “Near-Infrared Optical Imaging of Protease Activity for Tumor Detection,” Radiology 213:866-870 (1999).
Marks, J.D. et al., “By-Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling,” Biotech. 10:779-783 (1992).
McCafferty, J. et al., “Phage Antibodies: Filamentous Phage Displaying Antibody Variable Domains,” Nature 348:552-554 (1990).
Morrison, S.L., “Success in Specification,” Nature 368:812-813 (1994).
Needleman, S.B. et al., “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins,” J. Mol. Biol. 48:443-453 (1970).
Neuberger, M., “Generating High-Avidity Human Mabs in Mice,” Nature Biotech. 14:826 (1996).
Olafsen, T. et al., “Characterization of Engineered Anti-p185HER-2(scFv-CH3)2Antibody Fragments (Minibodies) for Tumor Targeting,” Protein Eng. Des. Sel. 17:315-323 (2004).
Olafsen, T. et al., “Optimizing Radiolabeled Engineered Anti-p185HER2Antibdy Fragments for In Vivo Imaging,” Cancer Res. 65:5907-5916 (2005).
Pearson, W.R. et al., “Improved Tools for Biological Sequence Comparison,” Proc. Natl. Acad. Sci. USA 85:2444-2448 (1988).
Ramanujam, N. et al., “Fast and Noninvasive Fluorescence Imaging of Biological Tissues In Vivo Using a Flying-Spot Scanner,” IEEE Trans. on Biomed. Eng. 48:1034-1041 (2001).
Schuurman, J. et al., “The Inter-Heavy Chain Disulfid
Olafsen Tove
Raubitschek Andrew A.
Wu Anna M.
City of Hope
Perkins Coie LLP
Schwadron Ron
Sliger Lauren
The Regents of the University of California
LandOfFree
Engineered anti-CD20 antibody fragments for in vivo... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Engineered anti-CD20 antibody fragments for in vivo..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Engineered anti-CD20 antibody fragments for in vivo... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4167296